This Biotech June Catalyst: What Investors Need to Know Now
A major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Assess whether Risk Parity or index funds better suit your retirement plan by examining diversification, cost, and potential risk/return trade-offs.
27,926 articlesA major fund trimmed its stake in a biotech ahead of a June FDA milestone. This article explains what that means for ...
Viral getaway trends can spark inspiration, but they don’t always deliver. This guide breaks down the costs, realitie...
Investors are watching alarm.com with a focus on how 2026 earnings will unfold. This guide explains the key drivers, ...
Higharc AI has closed a $95 million Series C, backed by USLBM, to accelerate AI-enabled homebuilding. The move aims t...
The eVTOL craze mixes hype with real engineering, regulatory hurdles, and capital burn. Here's why I wouldn't touch t...
Fresh NAEP data in early 2026 shows a broad but nuanced slide in reading and math for 4th and 8th graders, renewing d...
If you want to trim your monthly costs without a dramatic lifestyle change, you’re not alone. This guide shows practi...
Janet Jackson headlines a one-off UK show at Sandringham in 2026. This guide breaks down how to budget for tickets, t...
Sodexo is accelerating AI and robotics across its kitchen operations to cut labor costs, improve menu execution, and ...
A major fund is doubling down on Lionsgate Studios as shares skyrocket. Learn what know about this bet, the strategy ...
A niche nuclear tech stock reported solid revenue gains, but a large fund reduced its holdings. Learn how to read the...
A major fund recently reduced its exposure to Adaptive Biotechnologies, sparking questions about what institutional m...